NL-OMON56629尚未招募不适用
A prospective longitudinal study of spinal cord lesions in multiple sclerosis: MRI monitoring and prognostic factors for active disease - MSpine
Zuyderland Medisch Centrum0 个研究点目标入组 155 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 155
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Patients diagnosed with relapsing-remitting MS (<5 years of first clinical
- •Patient between 18-65 years old
- •Treatment-naïve patients starting (a currently in the Netherlands approved) DMT
- •(disease modifying treatment)
排除标准
- •Patients who are <18 years old
- •Patients who are >65 years old
- •Patients who presented first clinical event more than five years ago
- •Patients who have already started DMT
- •Patients who are incapable of giving informed consent
- •Patients who are unable to undergo local MRI scan, due to for instance:
- •Physical problems, for instance due to size/obesity (not fitting in regular MRI
- •scanner), not being able to lie flat for extended periods of time (e.g. due to
- •pain, shortness of breath). Due to claustrophobia.
- •Patients who have contraindications for MRI scan, for instance due to
- •MRI-unsafe or non-compatible implanted material/devices, such as pacemakers or
- •ocular metal splinters, or patients who are pregnant at inclusion.
研究者
相似试验
尚未招募
不适用
The effects of spinal cord stimulation on nerve function in low back paiower back painLower back painMusculoskeletal - Other muscular and skeletal disordersNeurological - Other neurological disordersACTRN12617000239369orthern Sydney Local Health District30
尚未招募
不适用
Study on spinal anaesthesia failures in caesarean operatioCTRI/2021/01/030255Dr Suvarna Kaniyil
尚未招募
不适用
Elucidation of the effect of short-term spinal cord stimulation therapy on resting state functional connectivity networkintractable pain in limbsJPRN-UMIN000031253Division of Anesthesiology, Department of Surgery Related,Kobe university graduate school of medicine60
进行中（未招募）
1 期
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 in Clinical TrialsMedDRA version: 20.1Level: PTClassification code 10041582Term: Spinal muscular atrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersSpinal Muscular AtrophyEUCTR2021-006781-21-BEovartis Pharma AG260
进行中（未招募）
1 期
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 in Clinical TrialsMedDRA version: 20.1Level: PTClassification code 10041582Term: Spinal muscular atrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersSpinal Muscular AtrophyEUCTR2021-006781-21-FRovartis Pharma AG260